Bebangco, Baby Girl .
HRN: 28-09-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/13/2025
11/20/2025
IV
120mg
Q6
T/C Omphalitis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes